Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, 675 Charles E. Young Drive, Los Angeles, CA 90095, USA.
Endocrinology. 2011 Dec;152(12):4571-80. doi: 10.1210/en.2011-1170. Epub 2011 Oct 18.
Substance P (SP), encoded by the tachykinin 1 (Tac1) gene, is the most potent tachykinin ligand for the high-affinity neurokinin-1 receptor (NK-1R). We previously reported that NK-1R-deficient mice show less weight gain and reduced circulating levels of leptin and insulin in response to a high-fat diet (HFD) and demonstrated the presence of functional NK-1R in isolated human preadipocytes. Here we assessed the effects of SP on weight gain in response to HFD and determined glucose metabolism in Tac1-deficient (Tac1(-/-)) mice. The effect of SP on the expression of molecules that may predispose to reduced glucose uptake was also determined in isolated human mesenteric, omental, and sc preadipocytes. We show that although weight accumulation in response to HFD was similar between Tac1(-/-) mice and wild-type littermates, Tac1(-/-) mice demonstrated lower glucose and leptin and increased adiponectin blood levels and showed improved responses to insulin challenge after HFD. SP stimulated phosphorylation of c-Jun N-terminal kinase, protein kinase C, mammalian target of rapamycin, and inhibitory serine insulin receptor substrate-1 phosphorylation in human preadipocytes in vitro. Preincubation of human mesenteric preadipocytes with the protein kinase C pseudosubstrate inhibitor reduced insulin receptor substrate 1 phosphorylation in response to SP. Lastly, SP also induced insulin receptor substrate-1 phosphorylation in mature human sc adipocytes. Our results demonstrate an important role for SP in adipose tissue responses and obesity-associated pathologies. These novel SP effects on molecules that enhance insulin resistance at the adipocyte level may reflect an important role for this peptide in the pathophysiology of type 2 diabetes.
P 物质(SP)是速激肽 1(Tac1)基因编码的最强的速激肽配体,可与高亲和力神经激肽 1 受体(NK-1R)结合。我们之前报道过,NK-1R 缺陷型小鼠在高脂肪饮食(HFD)的刺激下体重增加较少,且循环瘦素和胰岛素水平降低,并证明了分离的人前体脂肪细胞中存在功能性 NK-1R。在这里,我们评估了 SP 对 HFD 刺激体重增加的影响,并确定了 Tac1 缺陷(Tac1(-/-))小鼠的葡萄糖代谢情况。还在分离的人肠系膜、网膜和皮下前体脂肪细胞中确定了 SP 对可能导致葡萄糖摄取减少的分子表达的影响。我们发现,尽管 Tac1(-/-) 小鼠和野生型同窝仔鼠对 HFD 的反应体重增加相似,但 Tac1(-/-) 小鼠的血糖和瘦素水平较低,脂联素水平升高,并且在 HFD 后对胰岛素刺激的反应更好。SP 在体外刺激人前体脂肪细胞中 c-Jun N-末端激酶、蛋白激酶 C、哺乳动物雷帕霉素靶蛋白和抑制性丝氨酸胰岛素受体底物-1 的磷酸化。在人肠系膜前体脂肪细胞中预先孵育蛋白激酶 C 假底物抑制剂可减少 SP 对胰岛素受体底物 1 的磷酸化。最后,SP 还诱导成熟的人皮下脂肪细胞中胰岛素受体底物-1 的磷酸化。我们的研究结果表明 SP 在脂肪组织反应和肥胖相关病理中起重要作用。这些 SP 对增强脂肪细胞水平胰岛素抵抗的分子的新作用可能反映了该肽在 2 型糖尿病病理生理学中的重要作用。